Rationale for choice of lymphodesection tactics in patients with uterine body cancer

Abstract

the last 30 years in Eastern Europe, uterine cancer ranks second in the structure of oncogynecological pathology, and the annual increase in morbidity is estimated at 2–7%. Cancer of the uterine body ranks seventh in the world structure of the incidence of oncogynecological pathology, and in the structure of the incidence of cancer in the female population in the CIS – third place. Unsatisfactory statistical data pose a pressing issue to the modern scientific community of rationalization of treatment methods and, in particular, approaches to the choice of lymph dissection.